Blackstone Inc’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$440K Sell
12,447
-79,925
-87% -$2.36M ﹤0.01% 374
2026
Q1
$2.56M Sell
92,372
-130,872
-59% -$3.36M 0.01% 188
2025
Q4
$4.84M Buy
223,244
+88,426
+66% +$1.74M 0.02% 121
2025
Q3
$2.04M Buy
+134,818
New +$1.67M 0.01% 139

Other funds holding ROIV

Blackstone Inc's ROIV Position: Q2 2026 in Review

Blackstone Inc reduced its Roivant Sciences (ROIV) stake by 87% in Q2 2026, selling an estimated $2.36M and leaving 12,447 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #374.

Blackstone Inc first reported a position in ROIV in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.84M in Q4 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Blackstone Inc held 12,447 shares of Roivant Sciences worth $440K as of Q2 2026.
  • Blackstone Inc sold 79,925 Roivant Sciences shares in Q2 2026, an estimated $2.36M.
  • Roivant Sciences made up ﹤0.01% of Blackstone Inc's portfolio in Q2 2026, its #374 holding.
  • Blackstone Inc first reported a position in Roivant Sciences in Q3 2025 and has held it in 4 quarters since.
  • Blackstone Inc's Roivant Sciences position peaked at $4.84M in Q4 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.